Skip to main content
OpenTrials
Completed

NCT Number: NCT05884047

The Effect Of Virtual Reality Glasses On Vital Signs And State Anxiety Level In Cancer Patients

This study was conducted as a non-randomized control group experimental study to determine the effect of virtual reality glasses on vital signs and state anxiety levels.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Patients Anxiety Disorders Mental Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bahar İnkaya

Ankara, 060, Turkey (Türkiye)

About this study

Purpose This study was conducted as a non-randomized control group experimental study to determine the effect of virtual reality glasses on vital signs and state anxiety levels in cancer patients receiving chemotherapy for the first time.

Methods and Sample The population of the study was composed of adult patients admitted to an oncology hospital in Ankara province with a diagnosis of stage I-II-III cancer to undergo chemotherapy treatment for the first time. The sample of the study consisted of 30 patients who were assigned to the intervention and control groups by the stratified sampling method (considering such characteristics as age, gender, marital status). The patient identification form, Spielberger state anxiety scale, patient opinion form, vital signs follow-up form, and virtual reality glasses were used to collect the data.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with stage 1,2,3 cancer
  • Receive radiotherapy and chemotherapy for the first time
  • Volunteer patients who agreed to participate

Exclusion criteria

-Patients outside the inclusion criteria

Treatment and study plan

Virtual Glasses

Device

In the research, Samsung Gear VR SM-R323 brand and model SG glasses provided by the researcher were used. Patients were offered four different options to watch as "Forest of Serenity", "Calm Place", "Happy Place", "Gala 360 Travel & Relax". Forest of Serenity is a nature video consisting of bird sounds, colorful trees and flowers, and a clear lake where fish can be seen swimming in it. Calm Place is a relaxing video where cycles are shown 24 hours a day, where a person finds himself by the lake in the forest in snowy, rainy sunny weather. In Happy Place, one finds himself in a virtual camp environment where natural events such as dynamically changing weather, day-night cycles, and falling stars are experienced. Gala 360 Travel & Relax is a Paris-Notre Dame museum tour video.

Primary outcomes

  1. Vital signs- Blood pressure

    Time frame: first measurement just before the start of the chemotherapy infusion

    Systolic blood pressure values

  2. Vital signs-pulse

    Time frame: first measurement just before the start of the chemotherapy infusion

    Pulse values

  3. Vital signs- Blood pressure

    Time frame: the last measurement just after the end of the chemotherapy infusion

    Systolic blood pressure values

  4. Vital signs-pulse

    Time frame: the last measurement just after the end of the chemotherapy infusion

    Pulse values

Sponsors and collaborators

Lead sponsor

Bahar İNKAYA

Other

Registry information

Official study title

The Effect Of Virtual Reality Glasses On Vital Signs And State Anxiety Level In Cancer Patients Receiving Chemotherapy For The First Time- Randomized Control Trial

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 1, 2023
Registry last updated
Jun 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.